The p53 Tumor Suppressor Pathway and Cancer
The current year (2004) marks the Silver Anniversary of the discovery of the p53 tumor suppressor. The emerging ?eld ?rst considered p53 as a viral antigen and then as an oncogene that cooperates with activated ras in transforming primary cells in culture. Fueling the concept of p53 acting as a tran...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Boston, MA :
Springer US,
2005.
|
Σειρά: | Protein Reviews ;
2 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- The p53 Network
- The Three-Dimensional Structure of p53
- Transcriptional Activation by p53: Mechanisms and Targeted Genes
- Transcriptional Repression by the p53 Tumor Suppressor Protein
- Posttranslational Modifications of p53: Upstream Signaling Pathways
- p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
- MDM2 and MDMX Regulators of p53 Activity
- p53 Family Members: p63 and p73
- The Oncogenic Activity of p53 Mutants
- Therapeutic Strategies Based on Pharmacological Modulation of p53 Pathway.